A detailed history of Franklin Resources Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 263,748 shares of BCRX stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
263,748
Previous 94,958 177.75%
Holding current value
$2 Million
Previous $586,000 241.98%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.41 - $8.69 $1.08 Million - $1.47 Million
168,790 Added 177.75%
263,748 $2 Million
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $74,468 - $122,430
18,031 Added 23.44%
94,958 $586,000
Q1 2024

May 13, 2024

BUY
$4.89 - $7.65 $376,173 - $588,491
76,927 New
76,927 $390,000
Q4 2022

Feb 10, 2023

BUY
$10.5 - $14.2 $151,347 - $204,678
14,414 New
14,414 $165,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.